Tim Mikhelashvili
Tim Mikhelashvili is the Founder and CEO of Amedea Pharma, Inc. and also a Director, Medical Science Liaison at UroGen Pharma. He is a Doctor of Pharmacy with a Post-Doctoral Fellowship in Scientific Publications and Medical Education from Rutgers with 16 years of experience in headquarters and field-based Medical Science Liaison and Trainer roles spanning both large, established companies such as Sanofi and AstraZeneca early in his career, as well as rare disease start-up companies such as Salix, Baxalta, Synergy, and UroGen. Passionate about company culture and performance metrics, he has driven company-wide leadership initiatives. He is certified by MIT Sloan in “Leading Organizational Change”, and is currently focused on transforming the Medical Affairs function to take the lead in helping the pharmaceutical industry grow its reputation and trust from patients and providers.
Amedea Pharma, Inc. is his organizational and performance management consulting company inspired by innovative analytic techniques “to transform numbers into stories”, meanings, and future behaviors. He advises artificial intelligence start-ups and professional societies, writes articles, creates and delivers courses and webinars about Field Medical Insights, Metrics, and Virtual Engagement. Finally, Tim is the host of his inspirational @Alloutcoach Podcast and YouTube Channel dedicated to breaking down barriers between people and extending the boundaries of human responsibilities and abilities, where his slogan is “stretch yourself, lift others”, and his personal goal is to create more leaders.
Meg Heim
Meg Heim as VP, Global Head Strategic Scientific Engagement, Operations and Program Management, is a key member of the CMO Office. Meg’s role participates as a member of various Global teams and committees to further strengthen and globalize the Medical function across all Business Units and Countries.
Meg is responsible for crafting and executing the Integrated Scientific Strategy, harmonize Medical Systems, CRMs, Transparency Systems and lead the Innovative Scientific Congress model of the future.
Meg has held officer roles and Executive Global Medical, Sales and Marketing positions with a number of healthcare, medical device and health information technology companies.
Meg is a Registered Nurse with a Masters in Administrative Science, with Post Masters certificates in Non-Profit Organizational Development and Global Leadership from Fairleigh Dickinson University.
Tamas Koncz
Tamas Koncz, MD, MSc, Ph.D., is Chief Medical Officer (CMO) for the Inflammation and Immunology (I&I) Business at Pfizer. As CMO, Tamas leads the medical affairs organization, medical professionals across the world who are responsible for ensuring the safe and effective use of Pfizer I&I medicines, as well as continuous data generation and dissemination to advance the understanding of the medicines’ benefit: risk profiles. Medical affair colleagues are also involved in projects supporting research and early and late phase development, regulatory affairs, reimbursement and lifecycle management of the medicines. Throughout his career, Tamas has held various roles as a VP Global TA Lead, Global and European Medical Director, UK country medical adviser, health economist working with a broad portfolio and medical devices. Tamas holds an MD from the University of Debrecen, Hungary. Additionally, he completed an MSc in Economics at the Corvinus University, Budapest, an MSc in Health Economics at the University of York, UK and an MSc in Pharmaceutical Medicine at the University of Surrey, UK. Tamas also holds a Ph.D. from Semmelweis University, Hungary.